Joshua Fowler
Psychiatry · Columbia, SCNPI 1487939070
Payments from drug & device makers
Across 231 payments — averaging $9.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$755
- Ironshore Pharmaceuticals Inc.$459
- Corium, LLC$173
- Otsuka America Pharmaceutical, Inc.$142
- Johnson & Johnson$117
- Vanda Pharmaceuticals Inc.$106
- plus $400 from 12 others
What the payments were for
- Food & beverage$2,153100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 136 | $755 |
| Ironshore Pharmaceuticals Inc. | 27 | $459 |
| Corium, LLC | 25 | $173 |
| Otsuka America Pharmaceutical, Inc. | 8 | $142 |
| Johnson & Johnson | 6 | $117 |
| Vanda Pharmaceuticals Inc. | 6 | $106 |
| Lundbeck LLC | 4 | $76 |
| Supernus Pharmaceuticals, Inc. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Neurocrine Biosciences, Inc. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Tris Pharma Inc | 1 | $21 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Aytu Biopharma, Inc. | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $13 |
How this compares
$2,153 in reported general payments places this provider in the 75th percentile of 624 psychiatry providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 31 | $65,110 |
| FanaptIloperidone | 29 | $42,332 |
| Abilify MaintenaAripiprazole | 14 | $40,672 |
| Chlorpromazine Hcl | 117 | $40,013 |
| Risperdal ConstaRisperidone Microspheres | 14 | $36,658 |
| Divalproex Sodium | 178 | $15,244 |
| Divalproex Sodium ErDivalproex Sodium | 280 | $15,242 |
| Aripiprazole | 365 | $11,949 |
| TrintellixVortioxetine Hydrobromide | 18 | $11,370 |
| Paliperidone ErPaliperidone | 60 | $10,129 |
| Quetiapine Fumarate | 603 | $9,763 |
| Risperidone | 850 | $8,529 |
| Haloperidol | 157 | $5,143 |
| LoxapineLoxapine Succinate | 25 | $4,754 |
| Asenapine Maleate | 26 | $4,630 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $755 | $65,11031 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $106 | $42,33229 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $142 | $40,67214 claims |
| Johnson & JohnsonRisperdal Consta | $117 | $36,65814 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $49 | $15,80229 claims |
| Teva Pharmaceuticals USA, Inc.Loxapine | $25 | $4,75425 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 624 psychiatry providers in South Carolina.
Other psychiatry in Columbia
- Meera NarasimhanColumbia$146K
- Gariane GunterColumbia$46K
- Deborah LeveretteColumbia$11K
- Nioaka CampbellColumbia$11K
- Timothy MaloneColumbia$7K
- Kelly DionColumbia$7K
- Jacobo MintzerCharleston$4.9M
- Paul RobbinsSummerville$1.2M
- Brittany AlbrightMount Pleasant$691K
- Eduardo CifuentesCharleston$675K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.